论文部分内容阅读
2016年5月20日,国家卫生计生委公布经药品价格谈判部际联席会议审议通过后的国家药品价格谈判结果,公布的3种专利药品吉非替尼、埃克替尼和替诺福韦价格降幅均超过50%。国家药品价格谈判第一单宣告敲定,从此撬开了原研药、专利药坚固的价格坚冰。首开国家谈判先河国家药品价格谈判是指以国家作
On May 20, 2016, the National Health and Family Planning Commission announced the results of the negotiations on the state drug prices after the inter-ministerial joint meeting on drug price negotiations announced that the three patented drugs, gefitinib, icotinib and tenofovir Prices have dropped more than 50%. National drug price negotiations announced the first single finalized, from prized open the original research medicine, patented drugs strong price of ice. The first country to negotiate the national negotiating state drug price negotiations refer to the country